Trump hints at ending pharmaceutical tariff exemptions
In a move that could disrupt global trade dynamics, former President Donald Trump signaled his intent to revoke tariff exemptions for pharmaceutical products. This announcement has raised concerns among industry leaders and international partners, as such a decision could significantly impact the cost and availability of essential medications worldwide.The pharmaceutical industry, which relies heavily on global supply chains, has benefited from longstanding trade agreements that allow many drugs and raw materials to move across borders without additional taxes. These exemptions have been crucial in maintaining competitive pricing and ensuring consistent access to life-saving treatments. However, Trump's rhetoric suggests a shift…